Our business will be closed from December 24 to January 2. Please place your 2024 orders by December 18. For orders from Malaysia, please place them by December 9. Wishing you happy holidays! 

BDI - FastScreen for Medical Patients

BDI-FS
  • Aaron T. Beck, MD
  • Robert A. Steer
  • Gregory K. Brown

Quickly screen for depression in adolescents and adults with the new BDI® – FastScreen for Medical Patients. A new version of the Beck Depression Inventory®–II designed specifically for medical patients. BDI® – FastScreen is a reliable 7-item self-report instrument useful for case-finding.

Choose from our formats

  • Kits

    Starter & complete kits, print & digital

    1 option

    From USD 165.26
  • Test forms reports

    Booklets, record forms, answer sheets, report usages & subscriptions

    1 option

    From USD 86.94
  • Support materials

    Manuals, stimulus books, replacement items & other materials

    1 option

    From USD 126.96
  • All products

    All tests and materials offered for BDI-FS

    3 options

    From USD 86.94
- of 3 results
  • BDI-Fastscreen For Medical Patients Manual (Print)
    0158019423 Qualification Level B

    USD 126.96

  • BDI-Fastscreen For Medical Patients Complete Kit (Print)
    0158019415 Qualification Level B

    Includes Manual (Print) and pad of 50 Record Forms (Print)

    USD 165.26

    Estimated to ship:1-2 weeks
  • BDI-Fastscreen Response Sheets Qty 50 (Print)
    0158019431 Qualification Level B

    USD 86.94

Overview

Publication date:

2000

Age range:

13 through 80 years

Completion time:

Less than 5 minutes

Product Details

Features and Benefits

  • This cost-effective, focused evaluation tool is self-administered in just a few minutes and easily scored by office staff
  • Measures the severity of depressive symptoms corresponding to the psychological, nonsomatic criteria for diagnosing major Depressive Disorders in the DSM– IV.
  • Helps quantify depression, while excluding symptoms that might be related to medical problems. (Evaluates depression in patients whose behavioral and somatic symptoms attributable to biological, medical, alcohol and/or substance abuse problems may confound diagnosis.)